Statements March 18, 2026
IMC Statement on new federal government task force
Ottawa, March 18, 2026 – Canada must strengthen its approach to pharmaceutical innovation in a rapidly evolving global environment. Today’s […]
All news
Stay informed with the latest press releases, industry updates, and insights from Innovative Medicines Canada.
Filter by
Statements December 04, 2025
IMC congratulates the government of Québec on launching the new Québec life sciences strategy
Ottawa, December 4, 2025 — Innovative Medicines Canada (IMC) congratulates the Government of Québec on the launch of the new […]
Statements November 04, 2025
Federal budget statement
November 4, 2025 (Ottawa)—Today’s federal budget outlined ambitious plans to reduce government spending while making generational investments to strengthen Canada’s […]
Statements June 12, 2025
Open letter
Dear G7 Governments, On behalf of the innovative pharmaceutical industry we represent, we would like to convey ahead of the […]
Statements May 27, 2025
IMC responds to the speech from the throne
Ottawa, May 27, 2025 – Today, His Majesty King Charles III delivered the Speech from the Throne, outlining the federal […]
Statements May 26, 2025
Innovative Medicines Canada statement of support for CanReview
Ottawa, May 26, 2025 – Innovative Medicines Canada welcomes the launch of CanReview, a pan-Canadian initiative supported by the Accelerating […]
Statements March 27, 2025
Innovative Medicines Canada’s response to Quebec’s 2025-26 budget
Quebec City, March 27, 2025 – Amidst geopolitical and economic uncertainties, Quebec released their 2025-26 budget on Tuesday with focus […]
Statements December 16, 2024
Statement from Innovative Medicines Canada on the release of the 2024 federal fall economic statement
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
Statements November 15, 2024
Statement from Innovative Medicines Canada on the committee of experts to make recommendations on national pharmacare
We are disappointed to see that, once again, the government has excluded the pharmaceutical industry’s voice from important discussions on […]
Statements October 15, 2024
Statement from Innovative Medicines Canada on Ontario’s next phase of the life sciences strategy
Today’s announcement by the Ontario government of a $146 million investment in the next phase of the Life Sciences Strategy […]
Statements October 11, 2024
Statement from Innovative Medicines Canada on the passage of Bill C-64, the pharmacare act
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Statements October 03, 2024
Statement from Innovative Medicines Canada in response to minister Holland’s letter to SOCI
“Minister Holland’s recent letter to SOCI regarding the impact of Bill C-64 on private insurance in Canada confirms our concerns: […]
